High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome
- 4 February 2012
- journal article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 28 (9) , 722-725
Abstract
Objectives: Polycystic ovary syndrome (PCOS) is characterized by insulin resistance. Chronic low-grade inflammation has been anticipated to play role in the pathogenesis of both insulin resistance and atherosclerosis. Pentraxin 3 (PTX3) is an inflammatory mediator synthesized in a variety of cells and tissues including heart, vascular endothelial cells, macrophages and adipocytes. In the present study, serum PTX3 level and its relationship with insulin resistance were investigated in patients with PCOS. Materials and Methods: Forty patients with PCOS and 40 age- and body mass index (BMI)-matched healthy controls were enrolled in the study. PTX3 and high-sensitivity C-reactive protein (hs-CRP) levels were determined by enzyme immunoassay (EIA). Insulin resistance was calculated by the homeostasis model assessment of insulin resistance (HOMA-IR) formula. Results: Plasma levels of PTX3, hs-CRP and HOMA-IR scores were all significantly higher (p = 0.021, p = 0.002 and p = 0.0001, respectively) in women with PCOS compared with healthy controls. Blood PTX3 level correlated positively with hs-CRP, BMI, waist-to-hip ratio (WHR), HOMA-IR and negatively with high-density lipoprotein cholesterol level (p < 0.05, for all). After adjustment for age and BMI, PTX3, total testosterone levels and BMI remained as independent predictors of HOMA-IR scores (p < 0.05, for all). Conclusion: PTX3 level is increased in patients with PCOS in concordance with insulin resistance.Keywords
This publication has 23 references indexed in Scilit:
- Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to AdiposityMediators of Inflammation, 2010
- Pentraxin 3 as a Novel Marker Predicting Congestive Heart Failure in Subjects With Acute Coronary SyndromeKorean Circulation Journal, 2010
- Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factorsAtherosclerosis, 2009
- Insulin resistance and polycystic ovary syndromeNutrition, Metabolism and Cardiovascular Diseases, 2008
- Inflamed adipose tissue, insulin resistance and vascular injuryDiabetes/Metabolism Research and Reviews, 2008
- PENTRAXINS AT THE CROSSROADS BETWEEN INNATE IMMUNITY, INFLAMMATION, MATRIX DEPOSITION, AND FEMALE FERTILITYAnnual Review of Immunology, 2005
- Increased C-Reactive Protein Levels in the Polycystic Ovary Syndrome: A Marker of Cardiovascular DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2004
- Detecting Insulin Resistance in Polycystic Ovary Syndrome: Purposes and PitfallsObstetrical & Gynecological Survey, 2004
- Inflammation and Insulin ResistanceDiabetes Care, 2003
- Multimer Formation and Ligand Recognition by the Long Pentraxin PTX3Journal of Biological Chemistry, 1997